IPP Bureau
Shiva Pharmachem files DRHP for its Rs. 900 crore IPO
By IPP Bureau - August 22, 2023
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
Jiangsu Hengrui Pharmaceuticals gets NMPA approval of oteseconazole Ccapsules
By IPP Bureau - August 22, 2023
Oteseconazole Capsules were found to be safe and more effective than fluconazole
EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
By IPP Bureau - August 21, 2023
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
Venus Remedies launches its flagship R&D drug Elores in Oman
By IPP Bureau - August 21, 2023
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Dr. Reddy's appoints Sunil Gavaskar as the brand ambassador for its #TensionMatLo campaign
By IPP Bureau - August 21, 2023
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Healthcare is not just a sector, but a mission: Dr. Mansukh Mandaviya
By IPP Bureau - August 21, 2023
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
G20 Health Minister’s Meeting concludes in Gandhinagar, Gujarat
By IPP Bureau - August 21, 2023
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
ABB India bags automation order for Reliance Life Sciences' biopharmaceutical facilities
By IPP Bureau - August 21, 2023
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Dr. Agarwal's Health Care raises US$80 mn from TPG and Temasek to expand network to 300 hospitals
By IPP Bureau - August 20, 2023
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Lupin receives approval from USFDA for Bromfenac Ophthalmic
By IPP Bureau - August 20, 2023
Bromfenac Ophthalmic Solution 0.09% (RLD Bromday) had estimated annual sales of USD 11 million in the U.S. (IQVIA MAT June 2023).
Lupin acquires Boehringer Ingelheim's brands Ondero and Ondero Met to expand diabetes portfolio in India
By IPP Bureau - August 19, 2023
This acquisition strengthens Lupin's commitment to providing superior treatment options for patients navigating the complexities of diabetes
Collaborative efforts and equitable access to diagnostic prevention needed to end TB: Dr. Mandaviya
By IPP Bureau - August 19, 2023
Combating the prevalent stigma against TB in the society, India has been committed to providing, enabling and patient-centric support to all, individuals suffering from TB
India's Medical Value sector projected to reach $ 13 billion by 2026: Dr Mandaviya
By IPP Bureau - August 18, 2023
Need to harmonize traditional and modern medicine to combat alarming health problems
Honeywell, Recipharm to speed development of inhalers
By IPP Bureau - August 18, 2023
Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs
